Springleaf downgraded at Sterne Agee

theflyonthewall.com

As noted earlier, Sterne Agee downgraded Springleaf to Neutral from Buy. As reasons for the downgrade, the firm cited valuation and its belief that the pipeline for acquisitions isn't particularly rosy at this time.Price target $28.

View Comments (0)